Mucinex

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instance_of gptkb:pharmaceuticals
gptkbp:age_group 12 years and older
gptkbp:approves gptkb:2002
gptkbp:available_on gptkb:pharmaceuticals
gptkbp:brand gptkb:Mucinex_DM
gptkb:Mucinex_Sinus-Max
Mucinex Fast-Max
Mucinex Children's
gptkbp:clinical_trial studied for efficacy in cough relief
studied for safety in children
gptkbp:contraindication allergy to guaifenesin
gptkbp:dosage_form extended-release tablet
liquid syrup
gptkbp:form gptkb:tablet
gptkb:liquid
https://www.w3.org/2000/01/rdf-schema#label Mucinex
gptkbp:ingredients guaifenesin
sodium
coloring agents
artificial flavor
propylene glycol
sorbitol
gptkbp:interacts_with may interact with other medications
may interact with alcohol
gptkbp:is_effective_against effective for cough suppression
effective for mucus clearance
may cause increased mucus production
not a cough suppressant
gptkbp:manufacturer gptkb:Reckitt_Benckiser
gptkbp:packaging gptkb:bottle
blister pack
gptkbp:regulatory_compliance FDA approved
available in multiple countries
gptkbp:route_of_administration oral
gptkbp:side_effect dizziness
headache
nausea
allergic reaction
rash
drowsiness
dry mouth
gastrointestinal upset
gptkbp:storage store at room temperature
gptkbp:strength 600 mg
1200 mg
200 mg/5 m L
gptkbp:target_audience adults
children over 12
gptkbp:used_for relief of cough
thinning mucus
gptkbp:wildlife do not exceed recommended dose
consult doctor if breastfeeding
consult doctor if pregnant
consult doctor if taking other medications
gptkbp:bfsParent gptkb:Pfizer_Consumer_Healthcare
gptkb:Super_Bowl_XXXII
gptkb:Reckitt_Benckiser
gptkb:Vicks
gptkbp:bfsLayer 5